Tumor aware recurrent inter-patient deformable image registration of computed tomography scans with lung cancer

TL;DR

This paper introduces TRACER, a deep learning-based tumor-aware deformable image registration method that accurately aligns normal tissues and preserves tumor structures in lung cancer CT scans, improving radiotherapy planning accuracy.

Contribution

We developed a novel recurrent deep learning registration method that incorporates tumor segmentation and achieves superior tumor preservation compared to existing techniques.

Findings

TRACER accurately aligns normal tissues.

It best preserves tumors with minimal volume difference.

It reduces dose calculation errors in radiotherapy planning.

Abstract

Background: Voxel-based analysis (VBA) for population level radiotherapy (RT) outcomes modeling requires topology preserving inter-patient deformable image registration (DIR) that preserves tumors on moving images while avoiding unrealistic deformations due to tumors occurring on fixed images. Purpose: We developed a tumor-aware recurrent registration (TRACER) deep learning (DL) method and evaluated its suitability for VBA. Methods: TRACER consists of encoder layers implemented with stacked 3D convolutional long short term memory network (3D-CLSTM) followed by decoder and spatial transform layers to compute dense deformation vector field (DVF). Multiple CLSTM steps are used to compute a progressive sequence of deformations. Input conditioning was applied by including tumor segmentations with 3D image pairs as input channels. Bidirectional tumor rigidity, image similarity, and deformation smoothness losses were used to optimize the network in an unsupervised manner. TRACER and multiple DL methods were trained with 204 3D CT image pairs from patients with lung cancers (LC) and evaluated using (a) Dataset I (N = 308 pairs) with DL segmented LCs, (b) Dataset II (N = 765 pairs) with manually delineated LCs, and (c) Dataset III with 42 LC patients treated with RT. Results: TRACER accurately aligned normal tissues. It best preserved tumors, blackindicated by the smallest tumor volume difference of 0.24\%, 0.40\%, and 0.13 \% and mean square error in CT intensities of 0.005, 0.005, 0.004, computed between original and resampled moving image tumors, for Datasets I, II, and III, respectively. It resulted in the smallest planned RT tumor dose difference computed between original and resampled moving images of 0.01 Gy and 0.013 Gy when using a female and a male reference.